Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke (AusNanoMED)

NCT06495671 is registered in ClinicalTrials.gov with University of Melbourne as lead sponsor.

NCT NCT06495671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06495671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke (AusNanoMED)
Lead sponsor
University of Melbourne
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2024
Completion date
March 31, 2027
Enrollment
30 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, stroke